Gabriel Stancu
Affiliations: | 2012-2018 | Chemical Biology and Medicinal Chemistry | University of Texas at Austin, Austin, Texas, U.S.A. |
Google:
"Gabriel Stancu"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cho EJ, Devkota AK, Stancu G, et al. (2020) A Robust and Cost-Effective Luminescent-Based High-Throughput Assay for Fructose-1,6-Bisphosphate Aldolase A. Slas Discovery : Advancing Life Sciences R & D. 2472555220926146 |
| Qi R, Walker B, Jing Z, et al. (2019) Computational and Experimental Studies of Inhibitor Design for Aldolase A. The Journal of Physical Chemistry. B |
| Cho EJ, Devkota AK, Stancu G, et al. (2017) A Fluorescence-Based High-Throughput Assay for the Identification of Anticancer Reagents Targeting Fructose-1,6-Bisphosphate Aldolase. Slas Discovery. 2472555217726325 |
| Tavares CD, Giles DH, Stancu G, et al. (2016) Signal Integration at Elongation Factor 2 Kinase; the Roles of Calcium, Calmodulin and Ser-500 Phosphorylation. The Journal of Biological Chemistry |
| Grandjean G, De Jong PR, James BP, et al. (2016) Definition of a novel feed-forward mechanism for glycolysis-HIF1α signaling in hypoxic tumors highlights adolase A as a therapeutic target. Cancer Research |